Bio-Techne Corporation (NASDAQ:TECH) Q4 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Corporate Participants David Clair - Vice President, Investor Relations and Corporate Development Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Securities Jacob Johnson - Stephens Dan Arias - Stifel Catherine Schulte - Baird Alex Nowak - Craig-Hallum Patrick Donnelly - Citi Paul Knight - KeyBanc Operator Good morning, and welcome to th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2022 Earnings Conference Call May 4, 2022 9:00 AM ET Company Participants David Clair - Senior Director, IR and Corporate Development Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Dan Arias - Stifel Puneet Souda - SVB Securities Jacob Johnson - Stephens Alex Nowak - Craig-Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Paul Knight - KeyBanc Disclaimer*: This transcript is designed to be used alongside the freely available audio recording o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021, or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other ju ...

Bio-Techne Corporation (NASDAQ:TECH) Q2 2022 Earnings Conference Call February 1, 2022 9:00 AM ET Company Participants David Clair - Senior Director, IR and Corporate Development Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Dan Arias - Stifel Jacob Johnson - Stephens Inc. Patrick Donnelly - Citi Catherine Schulte - Baird Alex Nowak - Craig-Hallum Capital Group Operator Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other ...

Bio-Techne Corporation (NASDAQ:TECH) Q1 2022 Earnings Conference Call November 2, 2021 9:00 AM ET Company Participants David Clair - Senior Director, Investor Relations and Corporate Development Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Dan Arias - Stifel Jacob Johnson - Stephens Alex Nowak - Craig-Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Paul Knight - KeyBanc Capital Markets Operator Good morning and ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the ...

Bio-Techne Corporation (NASDAQ:TECH) Q4 2021 Earnings Conference Call August 5, 2021 9:00 AM ET Company Participants David Clair - Investor Relations Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Jacob Johnson - Stephens Catherine Schulte - Baird Alex Nowak - Craig-Hallum Patrick Donnelly - Citi Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2021. [Operator Instr ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2021 Earnings Conference Call May 6, 2021 9:00 AM ET Company Participants David Clair - Senior Director, Investor Relations and Corporate Development Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Puneet Souda - SVB Leerink Jacob Johnson - Stephens Alex Nowak - Craig-Hallum Capital Group Catherine Schulte - Baird Patrick Donnelly - Citi Paul Knight - Janney Montgomery Scott Operator Good mor ...